Accuray Incorporated - Asset Resilience Ratio
Accuray Incorporated (ARAY) has an Asset Resilience Ratio of 3.32% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ARAY working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2021)
This chart shows how Accuray Incorporated's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Accuray Incorporated total assets.
Liquid Assets Composition Over Time
This chart breaks down Accuray Incorporated's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore ARAY long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $15.94 Million | 3.32% |
| Total Liquid Assets | $15.94 Million | 3.32% |
Asset Resilience Insights
- Limited Liquidity: Accuray Incorporated maintains only 3.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Accuray Incorporated Industry Peers by Asset Resilience Ratio
Compare Accuray Incorporated's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Accuray Incorporated (2005–2021)
The table below shows the annual Asset Resilience Ratio data for Accuray Incorporated.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-06-30 | 3.32% | $15.94 Million | $480.10 Million | -- |
| 2018-06-30 | 0.00% | $0.00 | $378.73 Million | -- |
| 2017-06-30 | 5.88% | $23.91 Million | $406.46 Million | -4.19pp |
| 2016-06-30 | 10.07% | $47.24 Million | $469.03 Million | -3.61pp |
| 2015-06-30 | 13.68% | $64.31 Million | $469.97 Million | -2.38pp |
| 2014-06-30 | 16.07% | $79.55 Million | $495.19 Million | -5.17pp |
| 2013-06-30 | 21.24% | $101.08 Million | $475.93 Million | +20.91pp |
| 2012-06-30 | 0.33% | $1.56 Million | $473.17 Million | -0.37pp |
| 2011-06-30 | 0.70% | $3.17 Million | $455.78 Million | -37.26pp |
| 2010-06-30 | 37.95% | $99.88 Million | $263.18 Million | +14.40pp |
| 2009-06-30 | 23.56% | $64.63 Million | $274.39 Million | -5.44pp |
| 2008-06-30 | 28.99% | $85.54 Million | $295.00 Million | +28.99pp |
| 2006-06-30 | 0.00% | $1.00K | $138.62 Million | -0.18pp |
| 2005-06-30 | 0.18% | $158.00K | $86.86 Million | -- |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more